← Back to patent-cliff list
盐酸纳洛酮/盐酸羟考酮
Tier C — Watch / tradeNaloxone Hydrochloride/Oxycodone Hydrochloride Hydrate
Purdue Pharma
Originator
2006
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：Opioid receptors
Brand：Targin、Targiniq、奥施瑞定
Indications (approved)：疼痛、不宁腿综合征
Regional status
US
撤市
EU
批准上市
2006-01-01
China
批准上市
2022-11-22
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Naloxone Hydrochloride/Oxycodone Hydrochloride Hydrate?
Approved indications include: 疼痛, 不宁腿综合征.
When does the Naloxone Hydrochloride/Oxycodone Hydrochloride Hydrate patent expire?
No public expiry year is available for Naloxone Hydrochloride/Oxycodone Hydrochloride Hydrate yet; this page updates once verified.
How do I get a quote for Naloxone Hydrochloride/Oxycodone Hydrochloride Hydrate intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-24